logo

For the Inventor, By the Inventor

Warthausen, Germany

Klaus Reinhold Noll

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Dr. Karl Thomae Gmbh, Boehringer Ingelheim Gmbh, Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung. Active years: 1978-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Reinhold Noll. Retrieved from https://idiyas.com/inventor/klaus-reinhold-noll

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 7.2

ph-index = 9

Forward Citations = 264(Granted Patents)


Company Filing History:

goldMedal11 out of 133 
 
Dr. Karl Thomae Gmbh
 patents
silverMedal4 out of 306 
 
Boehringer Ingelheim Gmbh
 patents
bronzeMedal1 out of 21 
 
Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung
 patents

Years Active: 1978-1992

Loading Chart...
Areas of Expertise:
Cyclic Amine Derivatives
Heteroaromatic Amine Derivatives
Anti-Bacterial Compositions
Naphthyl Derivatives
Imidazo-Benzoxazinones
Substituted Bis-(4-Aminophenyl)-Sulfones
Benzazepine Derivatives
Cardiotonic Agents
Pharmaceutical Compositions
Esters
Amides
Antiphlogistic Compositions
16 patents (USPTO):Explore Patents
1. 5175157 - Cyclic amine derivatives, pharmaceutical compositions containing these (1992-12-29),
2. 5116986 - Heteroaromatic amine derivatives (1992-05-26),
3. 5084449 - Anti-bacterial compositions comprising a substituted (1992-01-28),
4. 4992430 - Anti-bacterial compositions comprising a substituted (1991-02-12),
5. 4912115 - Heteroaromatic amine derivatives, pharmaceutical compositions containing (1990-03-27),
6. 4871735 - Naphthyl derivatives, pharmaceutical compositions containing these (1989-10-03),
7. 4831027 - Imidazo-benzoxazinones, the preparation thereof and pharmaceutical (1989-05-16),
8. 4829058 - Substituted bis-(4-aminophenyl)-sulfones (1989-05-09),
9. 4737495 - (2H)-3-benzazepin-2-ones, their pharmaceutical compositions and their (1988-04-12),
10. 4716169 - Imidazo[1,2a]pyridines and their use as cardiotonic agents (1987-12-29),
11. 4604389 - Benzazepine derivatives (1986-08-05),
12. 4490369 - Benzazepine derivatives, their pharmaceutical compositions and method of (1984-12-25),
13. 4362738 - Esters and amides containing the (1982-12-07),
14. 4244967 - Antiphlogistic pharmaceutical compositions containing a (1981-01-13),
15. 4214001 - 1-(4-Acylamino-phenyl)-2-amino-ethanols and salts thereof (1980-07-22),

Certainly! Here is the article about inventor Klaus Reinhold Noll:

Title: Klaus Reinhold Noll: A Pioneer in Invention and Innovation

Introduction: Klaus Reinhold Noll, a visionary inventor hailing from Warthausen, Germany, stands as a beacon of inspiration in the realm of technological advancements. With a remarkable portfolio of 16 patents to his name, Noll has left an indelible mark on both technology and society through his unwavering dedication to innovation.

Latest Patents:

1. Cyclic amine derivatives: Noll's groundbreaking work on new cyclic amine derivatives has paved the way for innovative pharmaceutical compositions that hold promise in treating sinus tachycardia, a significant medical condition affecting many individuals.

2. Heteroaromatic amine derivatives: His contributions to the field of heteroaromatic amine derivatives have led to the development of compounds with valuable pharmacological properties, including heart rate lowering and positive inotropic activities.

Career Highlights: Noll's expertise and passion for invention have been honed through his tenure at renowned companies such as Dr. Karl Thomae GmbH and Boehringer Ingelheim GmbH. His innovative spirit and dedication to research have propelled him to the forefront of technological advancements in the pharmaceutical industry.

Collaborations: Throughout his career, Noll has collaborated with esteemed professionals in the field, including coworkers Joachim Heider and Norbert Hauel. Together, they have synergized their talents and insights to drive forward groundbreaking innovations that have the potential to revolutionize healthcare and pharmaceuticals.

Conclusion: In conclusion, Klaus Reinhold Noll's brilliant mind and relentless pursuit of innovation have not only reshaped the technological landscape but also inspired a new generation of inventors. His legacy will continue to shine bright, illuminating the path for future advancements in science and technology.

If you need further information or assistance, feel free to reach out!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…